Login / Signup

A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).

Mikkel BandakNiels JørgensenAnders JuulJakob LauritsenMichael KreibergPeter Sandor OturaiJørn Wulff HelgeGedske Daugaard
Published in: BMC cancer (2017)
ClinicalTrials.gov : NCT02991209 (November 25, 2016).
Keyphrases
  • replacement therapy
  • double blind
  • smoking cessation
  • randomized controlled trial
  • placebo controlled
  • clinical trial
  • young adults
  • single cell
  • phase iii
  • cell therapy
  • study protocol
  • bone marrow
  • mesenchymal stem cells